Genmab — Oktober 2020

[Helge_LarsenPI-redaktør]

Her virker det fint på alle enheder.

[troldmanden]

tror det er noget med når man ikke har haft PC slukket og den blot er i dvale. Uret viser også stadig sommertid i chatten hos mig

[E_L]

just close your browser & open again, or refresh page and should be fine

[E_L]

turned nicely on the 2194 Thursday low, let's see if it can turn into a small double bottom

[Plimsoller]

Still doesn't work after closing the browser, but I will reboot after work. Thanks for your help

[Vitus]

Er der ellers nogle holdninger til aktien

[GeorgeBest]

På lang sigt skal aktien up up and away. Pga epco, GEN1046, Amivantamab, Kesimpta. Genmab går fra at være en one trick pony, til et multiblockbuster biotech selskab

[GeorgeBest]

Specielt epco og GEN1046 er ekstremt vigtige da Genmabs ejerandel er 50%

[E_L]

GEN1046 could be the jackpot if it works as good as Jan thinks... but it will still take some time; i don't think the data in november will be able to show us the full potential yet

[GeorgeBest]

Agree

[E_L]

I think Amivantamab is vastly underrated.... JNJ is throwing a lot of effort into it and i think it will be filed sooner as expected -> double royalties at no cost to genmab

[nohope]

Estimated Primary Completion Date : April 30, 2024

[nohope]

Estimated Study Completion Date : November 20, 2025

[E_L]

is that Mariposa? we will not have to wait for that. they have breakthrough therapy designation from the FDA

[E_L]

and...

[E_L]

Pre-Approval Access With Amivantamab (JNJ-61186372) in Participants With Metastatic Non-Small Cell Lung Cancer https://clinicaltrials.gov/ct2/show/NCT04599712

[nohope]

Ok. Great

[Solsen]

It looks good EL - thanks.

[E_L]

The Phase 1 Talquetamab trial changed into a Phase 1/Phase 2 and increases enrollment from 185 to 245 https://clinicaltrials.gov/ct2/history/NCT03399799?A=20&B=21&C=merged#StudyPageTop

[E_L]

i hope that means the expansion phase is starting? maybe we can get some data at ASH ?